OPTH (Optimi Health) Growth Rank: 0 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OPTH Optimi Health Corp OPTH
25 GF Score
Price $4.96
GF Value $4.42
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Optimi Health Growth Rank?

Optimi Health has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

OPTH
25GF Score
Optimi Health Corp OPTH
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Optimi Health (OPTH) Overvalued in 2026?

Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued. The current stock price of $4.96 is trading 12.2% above its estimated GF Value™ of $4.42. GuruFocus considers Optimi Health to be Modestly Overvalued.

Key valuation signals for OPTH:

  • Growth Rank: 0
  • GF Value™: $4.42 vs. price of $4.96 (12.2% above fair value)
  • GF Score™: 25/100 with 4 warning signs

No single metric tells the full story. See the OPTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Optimi Health Business Description

Other Exchanges 8BN0:GermanyOPTI:Canada
Address 269 David Brown Way, Po Box 728, Princeton, BC, CAN, V0X 1W0
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
25GF Score

Get the complete analysis for OPTH

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.96
Price
$4.42
GF Value